Blockchain Registration Transaction Record

Telomir Pharmaceuticals Inc. Making Strides in Age Reversal Research with Telomir-1

Telomir Pharmaceuticals Inc. (NASDAQ: TELO) is gaining attention for its promising age reversal drug compound, Telomir-1, which has shown positive outcomes in a study with senior dogs. CEO Erez Aminov is dedicated to advancing the research necessary to bring this treatment to humans and pets.

Telomir Pharmaceuticals Inc. Making Strides in Age Reversal Research with Telomir-1

This news matters because Telomir-1's potential to reverse age-related conditions could have a significant impact on human and pet health. With positive preclinical trials and encouraging results from a study with senior dogs, the company is one to watch in the ongoing pursuit of age reversal solutions.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xa29fd8e2b8dc684be48ca35db9762c2b605463902cd6116345a89fe1d9e8c0c3
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintfileFBdO-8a469ee152f000325e9b5171d3b422d3